Wexford Capital Investments

Wexford Capital has invested in 21 companies and its latest investment was Nephros on Jul 08, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Nephros is a medical device company that develops and distributes water purification products for healthcare and commercial sectors.
$1.2M
Jul 08, 2021
-
Bonterra is a Canada-based exploration company that acquires and develops gold mining properties and produces gold.
$2.7M
Dec 14, 2020
-
R3 Vascular is a California-based medical device company that manufactures and supplies bioresorbable vascular scaffold products for the healthcare industry.
$17.8M
Oct 07, 2020
-
AZTherapies is a clinical-stage biopharmaceutical company that develops novel small molecules therapeutics to treat neurodegenerative diseases.
$33.6M
Sep 28, 2020
-
Viseon is a California-based medical device company that designs and distributes visualization equipment and related software for spine surgery.
$18M
Feb 24, 2020
-

Frequently Asked Questions about Wexford Capital

  1. What is Wexford Capital investing in?

    Wexford Capital has invested in 21 companies including Nephros, Bonterra and R3 Vascular
  2. What company did Wexford Capital invest in?

    Wexford Capital invested in a total 21 companies including Nephros, Bonterra and R3 Vascular
  1. What are the top 5 investments by Wexford Capital?

    The top companies in which Wexford Capital invested are Nephros, Bonterra, R3 Vascular, AZTherapies and Viseon